Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 7, 2002

View Archived Issues

Effective neuroprotection provided by new redox metabolic modulator

Neuroprotective estrogen analogue lacking hormonal effects characterized at Stroke conference

Cytokine-based gene therapy of brain ischemia promising according to Japanese research

Experiments link aromatase to neuroprotection in cerebral ischemia

Sildenafil demonstrates beneficial activity in rat model of cerebral ischemia

Glyceryl trinitrate reduces hypertension in stroke patients

Study finds oral contraceptives double the risk of first ischemic stroke

MEK1/2 inhibitor provides neuroprotection in cerebral ischemic injury

Xopenex approved for pediatric use in bronchospasm

Neurocrine updates clinical program progress in 2001

Gilead announces 2001 product highlights

Chlorambucil in the treatment of sight-threatening ocular inflammation

MCA approves phase II study of TTS in pancreatic cancer

CT-2106 cleared to enter phase I clinical testing

Encouraging results observed in phase IIa trial of AOD-9604 in obese patients

Novel dual gene therapy as a treatment for heart disease

Idun selects lead candidate for cardiovascular program

Sakai to codevelop and market Theratechnologies' ThGRF peptide in Japan

Amidine derivatives synthesized for neurological and neurodegenerative disorders

Takeda describes compounds for hyperlipidemia in recent patent

Merck discloses preparation and use of pyridine derivatives in CNS disorders

Nociceptin antagonists in the Banyu pipeline

New series from Taisho inhibits 20-HETE production

Acetylcholinesterase inhibitors described by Eisai for cognition disorders

Vitamin D analogues for the treatment of dermatoses

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...